Vimarsana
Biggest News Aggregation in the World

Page 9 - Scott Struthers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scott Struthers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scott Struthers Today - Breaking & Trending Today

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update - Vimarsana News

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Paltusotine’s Phase 3 PATHFNDR-1 study enrollment complete and topline data expected in 3Q 2023Paltusotine’s Phase 3 PATHFNDR-2 study enrollment ongoing with topline data now expected in... | February 28, 2023

Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 41st Annual J.P. Morgan Healthcare Conference - Vimarsana News

Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 41st Annual J.P. Morgan Healthcare Conference

09.01.2023 - Efforts to further increase commercial readiness ongoing as Phase 3 PATHFNDR trials of paltusotine in acromegaly approach topline data readouts which are expected in 2H 2023 Phase 2 trial of paltusotine in carcinoid syndrome on track for topline ... Seite 1

Enrollment Completed in Phase 3 PATHFNDR-1 Study Evaluating Oral Paltusotine for the Treatment of Acromegaly - Vimarsana News

Enrollment Completed in Phase 3 PATHFNDR-1 Study Evaluating Oral Paltusotine for the Treatment of Acromegaly

SAN DIEGO, Oct. 13, 2022 -- Crinetics Pharmaceuticals, Inc. today announced the completion of enrollment in the Phase 3 PATHFNDR-1 study. PATHFNDR-1 is one of two ongoing, placebo-controlled Phase... | October 13, 2022

Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as - Vimarsana News

Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as

SAN DIEGO, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the appointment of Dana Pizzuti, M.D., as...

Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer - Vimarsana News

Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer

Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer - read this article along with other careers information, tips and advice on BioSpace